Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
32991 | 99 | 26.6 | 49% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | REFLEXOL MANUAL THER Y | Address | 0 | 25% | 1% | 1 |
2 | 5 HYDROXYTRYPTAMINE1A | Author keyword | 0 | 20% | 1% | 1 |
3 | WORLDWIDE RD | Address | 0 | 11% | 1% | 1 |
4 | ANTI I A ANTIBODY | Author keyword | 0 | 100% | 1% | 1 |
5 | ANTI I E ANTIBODY | Author keyword | 0 | 100% | 1% | 1 |
6 | ANTI STOMACH SERUM | Author keyword | 0 | 100% | 1% | 1 |
7 | BULBOSPINAL PROJECTION | Author keyword | 0 | 100% | 1% | 1 |
8 | N 2 4 2 MEHOXYPHENIL 1 PIPERAZINYL ETHYL N 2 PYRIDINYLCYCLOHEXANECARBOXAMIDE | Author keyword | 0 | 100% | 1% | 1 |
9 | R 8 HYDROXY 2 DIPROPYLAMINO TETRALIN | Author keyword | 0 | 100% | 1% | 1 |
10 | SER 316 | Author keyword | 0 | 100% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HAPLOTYPE SPECIFIC SUPPRESSION | 2 | 67% | 2% | 2 |
2 | RECEPTOR INTERACTS | 1 | 50% | 1% | 1 |
3 | EXPERIMENTAL ALLERGIC ENCEPHALITIS | 0 | 33% | 1% | 1 |
4 | A MONOCLONAL ANTIBODIES | 0 | 25% | 1% | 1 |
5 | RESPONSE GENE PRODUCTS | 0 | 25% | 1% | 1 |
6 | PRESENTING CELL FUNCTION | 0 | 13% | 2% | 2 |
7 | SEROCYTOL | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
TREATMENT OF AUTOIMMUNE-DISEASES WITH ANTIBODIES TO CLASS-II MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS | 1991 | 7 | 62 | 31% |
Correlations between Pain Intensity and Levels of Natural Antibodies Against Pain-Processing Neuromediators in Patients with Chronic Dorsalgy | 2014 | 0 | 9 | 22% |
H-2-MOLECULES IN RECOGNITION OF THY-1 ANTIGENS - FACTS AND SPECULATIONS | 1981 | 8 | 3 | 67% |
IMMUNE SUPPRESSION AND IMMUNE MODULATION IN NEUROLOGICAL DISEASES - PRESENT STATE AND TRENDS | 1989 | 0 | 46 | 7% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REFLEXOL MANUAL THER Y | 0 | 25% | 1.0% | 1 |
2 | WORLDWIDE RD | 0 | 11% | 1.0% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000220888 | U396//HU1D10//UNITE 396 |
2 | 0.0000190923 | ANTI B CELL ANTIBODY//FOLLICULAR CENTER CELL//IN SITU IMMUNOPHENOTYPING |
3 | 0.0000185174 | JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY//TABM//GLYCOSYLATION INHIBITING FACTOR |
4 | 0.0000150250 | INTERDIGITATING RETICULUM CELL//DENDRITIC RETICULUM CELL//T HELPERS |
5 | 0.0000136343 | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS//MYELIN OLIGODENDROCYTE GLYCOPROTEIN//EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS |
6 | 0.0000117216 | ANTI CD4 MONOCLONAL ANTIBODY//ANTI ANTIBODIES//ANTI CD4 |
7 | 0.0000109453 | MURINE MAB//CYTOTOXICITY IMMUNOLOGICAL//DR2 HAPLOTYPES |
8 | 0.0000087598 | NEW ZEALAND MICE//RHEUMATOL CLIN MED//MRL LPR MICE |
9 | 0.0000086528 | AUTOLOGOUS MIXED LYMPHOCYTE REACTION//AUTOLOGOUS MIXED LYMPHOCYTE REACTION AMLR//MALIGNANT T CELLS |
10 | 0.0000071966 | ALLOANTIGEN SPECIFIC CYTOTOXIC T LYMPHOCYTES//ALPHA BETA TCR TRANSGENE//FOOTPAD IMMUNIZATION |